Our team, led by Dr. Arthur Agatston, is pioneering new approaches to proactive medicine. Through our collaborative research relationships, we are contributing to the development of the Agatston 2.0 protocol, an AI-enhanced low-radiation coronary calcium scoring to deliver personalized, predictive care. This technology, at no extra charge to our patients, offer evolving FDA-approved insights, such as bone mineral density
This next-generation approach allows us to:
• Identify cardiovascular and metabolic risks earlier than ever before
• Create tailored prevention plans based on each patient’s unique profile
• Continuously evolve through collaboration with leading institutions and technologies